These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23730839)

  • 1. Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co-infection and baseline anaemia.
    Erqou S; Mohanty A; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    J Viral Hepat; 2013 Jul; 20(7):463-9. PubMed ID: 23730839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia.
    Mohanty A; Erqou S; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):741-7.e3. PubMed ID: 23376794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hepatitis C virus and its treatment on survival.
    Butt AA; Wang X; Moore CG
    Hepatology; 2009 Aug; 50(2):387-92. PubMed ID: 19591128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.
    Vellozzi C; Buchacz K; Baker R; Spradling PR; Richardson J; Moorman A; Tedaldi E; Durham M; Ward J; Brooks JT;
    J Viral Hepat; 2011 May; 18(5):316-24. PubMed ID: 20367803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV.
    Ananthakrishnan AN; McGinley EL; Fangman J; Saeian K
    J Viral Hepat; 2010 Oct; 17(10):720-9. PubMed ID: 20002558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects.
    Butt AA; Justice AC; Skanderson M; Good C; Kwoh CK
    Aliment Pharmacol Ther; 2006 Aug; 24(4):585-91. PubMed ID: 16907891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival.
    Staples CT; Rimland D; Dudas D
    Clin Infect Dis; 1999 Jul; 29(1):150-4. PubMed ID: 10433578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of characteristics of treated and non-treated patients with Hepatitis C infection.
    Hare CB; Morris JA; Chu A; Gotz V; Loveland JJ; Hodes D; Klaskala W
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):71-6. PubMed ID: 16136612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study.
    Omland LH; Jepsen P; Skinhøj P; Jørgensen HL; Münster AM; Bangsborg J; Fenger M; Sørensen HT; Obel N
    HIV Med; 2009 Feb; 10(2):65-71. PubMed ID: 19018878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
    Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
    Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
    Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
    Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
    Tedaldi EM; Chen L; Markowitz N; Kelly L; Abrams D;
    J Viral Hepat; 2005 Jul; 12(4):414-20. PubMed ID: 15985013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.